意大利COVID-19住院患者肌钙蛋白水平与死亡率的关系:多中心研究
IMPORTANCE: Myocardial injury, detected by elevated plasma troponin levels, has been associated with mortality in patients hospitalized with coronavirus disease 2019 (COVID-19).…
要点
- COVID-19住院患者入院肌钙蛋白升高比例达45.3%,与院内死亡独立相关。
- 肌钙蛋白升高者年龄更大,高血压、心衰、冠心病、房颤患病率更高。
- 肌钙蛋白升高还关联心衰、脓毒症、急性肾衰、多器官衰竭等并发症风险增加。
核心结论
- 在意大利COVID-19住院患者中,入院肌钙蛋白升高是与院内死亡独立相关的变量,且独立于合并心脏疾病。
- 肌钙蛋白升高还与住院期间心血管和非心血管并发症风险增加相关。
研究设计与样本
- 多中心横断面研究,纳入2020年3月1日至4月9日在13个意大利心脏科单元连续住院的实验室确诊COVID-19患者。
- 排除因急性冠脉综合征入院的患者;肌钙蛋白升高定义为超过正常值第99百分位数。
- 共纳入614例患者,平均年龄67(SD 13)岁,男性占70.8%。
主要发现
- 148例(24.1%)患者在住院期间死亡,278例(45.3%)存在肌钙蛋白升高。
- 肌钙蛋白升高组较正常组年龄更大(平均71.3岁 vs 64.0岁,P<.001),高血压(65.9% vs 50.5%,P<.001)、心衰(22.8% vs 7.2%,P<.001)、冠心病(31.5% vs 15.0%,P<.001)、房颤(24.3% vs 9.9%,P<.001)患病率更高。
临床怎么用
- 对COVID-19住院患者应检测入院肌钙蛋白,以识别院内死亡和并发症高风险人群。
- 肌钙蛋白升高者需加强心血管及非心血管并发症监测,包括心衰、肾衰竭、脓毒症、血栓和出血事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Myocardial injury, detected by elevated plasma troponin levels, has been associated with mortality in patients hospitalized with coronavirus disease 2019 (COVID-19). However, the initial data were reported from single-center or 2-center studies in Chinese populations. Compared with these patients, European and US patients are older, with more comorbidities and higher mortality rates. OBJECTIVE: To evaluate the prevalence and prognostic value of myocardial injury, detected by elevated plasma troponin levels, in a large population of White Italian patients with COVID-19. DESIGN, SETTING, AND PARTICIPANTS: This is a multicenter, cross-sectional study enrolling consecutive patients with laboratory-confirmed COVID-19 who were hospitalized in 13 Italian cardiology units from March 1 to April 9, 2020. Patients admitted for acute coronary syndrome were excluded. Elevated troponin levels were defined as values greater than the 99th percentile of normal values. MAIN OUTCOMES AND MEASURES: Clinical characteristics and outcomes stratified as elevated or normal cardiac troponin levels at admission, defined as troponin T or troponin I at a level greater than the 99th percentile of normal values. RESULTS: A total of 614 patients with COVID-19 were included in this study (mean age [SD], 67 [13] years; 70.8% male), of whom 148 patients (24.1%) died during the hospitalization. Elevated troponin levels were found in 278 patients (45.3%). These patients were older (mean [SD] age, 64.0 [13.6] years vs 71.3 [12.0] years; P < .001) and had higher prevalence of hypertension (168 patients [50.5%] vs 182 patients [65.9%]; P < .001), heart failure (24 [7.2%]; 63 [22.8%]; P < .001), coronary artery disease (50 [15.0%] vs 87 [31.5%]; P < .001), and atrial fibrillation (33 [9.9%] vs 67 [24.3%]; P < .001). Elevated troponin levels were associated with an increased in-hospital mortality (37% vs 13%; HR, 1.71 [95% CI, 1.13-2.59]; P = .01 via multivariable Cox regression analysis), and this was independent from concomitant cardiac disease. Elevated troponin levels were also associated with a higher risk of in-hospital complications: heart failure (44 patients [19.2%] vs 7 patients [2.9%]; P < .001), sepsis (31 [11.7%] vs 21 [6.4%]; P = .03), acute kidney failure (41 [20.8%] vs 13 [6.2%]; P < .001), multiorgan failure (21 [10.9%] vs 6 [2.9%]; P = .003), pulmonary embolism (27 [9.9%] vs 17 [5.2%]; P = .04), delirium (13 [6.8%] vs 3 [1.5%]; P = .02), and major bleeding (16 [7.0%] vs 4 [1.6%]; P = .008). CONCLUSIONS AND RELEVANCE: In this multicenter, cross-sectional study of Italian patients with COVID-19, elevated troponin was an independent variable associated with in-hospital mortality and a greater risk of cardiovascular and noncardiovascular complications during a hospitalization for COVID-19.
引用
- Lombardi CM, Carubelli V, Iorio A, et al. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. JAMA Cardiol. 2020. PMID: 32845276. doi:10.1001/jamacardio.2020.3538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。